pediatrix medical group inc. - MD

MD

Close Chg Chg %
22.01 0.67 3.02%

Closed Market

22.68

+0.67 (3.02%)

Volume: 421.88K

Last Updated:

Jan 15, 2026, 3:59 PM EDT

Company Overview: pediatrix medical group inc. - MD

MD Key Data

Open

$22.08

Day Range

22.06 - 22.78

52 Week Range

11.84 - 24.99

Market Cap

$1.89B

Shares Outstanding

85.88M

Public Float

84.53M

Beta

0.74

Rev. Per Employee

N/A

P/E Ratio

11.70

EPS

$1.91

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

684.18K

 

MD Performance

1 Week
 
-1.43%
 
1 Month
 
0.50%
 
3 Months
 
33.86%
 
1 Year
 
59.10%
 
5 Years
 
-6.69%
 

MD Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About pediatrix medical group inc. - MD

Pediatrix Medical Group, Inc. engages in the provision of physician services. Its services include neonatal care, maternal fetal care, and other pediatric subspeciality care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

MD At a Glance

Pediatrix Medical Group, Inc.
1301 Concord Terrace
Sunrise, Florida 33323
Phone 1-954-384-0175 Revenue 2.01B
Industry Medical/Nursing Services Net Income -99,069,000.00
Sector Health Services 2024 Sales Growth 0.916%
Fiscal Year-end 12 / 2025 Employees 6,455
View SEC Filings

MD Valuation

P/E Current 11.704
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.543
Price to Book Ratio 1.473
Price to Cash Flow Ratio 5.29
Enterprise Value to EBITDA 6.517
Enterprise Value to Sales 0.699
Total Debt to Enterprise Value 0.471

MD Efficiency

Revenue/Employee 311,838.73
Income Per Employee -15,347.637
Receivables Turnover 7.384
Total Asset Turnover 0.921

MD Liquidity

Current Ratio 1.473
Quick Ratio 1.473
Cash Ratio 0.803

MD Profitability

Gross Margin 20.97
Operating Margin 9.125
Pretax Margin -5.035
Net Margin -4.922
Return on Assets -4.531
Return on Equity -12.276
Return on Total Capital -6.941
Return on Invested Capital -6.812

MD Capital Structure

Total Debt to Total Equity 86.584
Total Debt to Total Capital 46.405
Total Debt to Total Assets 30.767
Long-Term Debt to Equity 82.237
Long-Term Debt to Total Capital 44.075
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Pediatrix Medical Group Inc. - MD

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.91B 1.97B 1.99B 2.01B
Sales Growth
+10.22% +3.18% +1.15% +0.92%
Cost of Goods Sold (COGS) incl D&A
1.43B 1.54B 1.61B 1.59B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
32.15M 35.64M 36.17M 32.23M
Depreciation
21.60M 26.70M 28.10M 22.70M
Amortization of Intangibles
10.55M 8.94M 8.07M 9.53M
COGS Growth
+8.91% +7.73% +4.45% -1.15%
Gross Income
481.10M 431.40M 385.39M 422.12M
Gross Income Growth
+14.31% -10.33% -10.66% +9.53%
Gross Profit Margin
+25.17% +21.88% +19.32% +20.97%
2021 2022 2023 2024 5-year trend
SG&A Expense
263.36M 231.40M 227.54M 238.44M
Research & Development
- - - -
-
Other SG&A
263.36M 231.40M 227.54M 238.44M
SGA Growth
+5.79% -12.14% -1.67% +4.79%
Other Operating Expense
- - - -
-
Unusual Expense
36.63M 84.33M 170.53M 242.69M
EBIT after Unusual Expense
181.11M 115.67M (12.68M) (59.01M)
Non Operating Income/Expense
22.84M 5.39M 6.39M (1.58M)
Non-Operating Interest Income
13.65M 3.67M 4.34M 5.77M
Equity in Earnings of Affiliates
1.91M 1.72M 2.06M 2.34M
Interest Expense
68.72M 39.70M 42.08M 40.74M
Interest Expense Growth
-37.80% -42.24% +6.00% -3.17%
Gross Interest Expense
68.72M 39.70M 42.08M 40.74M
Interest Capitalized
- - - -
-
Pretax Income
135.23M 81.37M (48.36M) (101.34M)
Pretax Income Growth
+1,791.83% -39.83% -159.43% -109.56%
Pretax Margin
+7.08% +4.13% -2.42% -5.03%
Income Tax
27.24M 18.81M 12.05M (2.27M)
Income Tax - Current - Domestic
58.48M 41.58M 8.81M (142.00K)
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(31.24M) (22.77M) 3.24M (2.13M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
1.91M 1.72M 2.06M 2.34M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
107.99M 62.56M (60.41M) (99.07M)
Minority Interest Expense
- - (27.00K) (4.00K)
-
Net Income
108.01M 62.57M (60.41M) (99.07M)
Net Income Growth
+1,227.49% -42.07% -196.55% -64.00%
Net Margin Growth
+5.65% +3.17% -3.03% -4.92%
Extraordinaries & Discontinued Operations
- - 22.95M 3.77M
-
Discontinued Operations
- - 22.95M 3.77M
-
Net Income After Extraordinaries
130.96M 66.33M (60.41M) (99.07M)
Preferred Dividends
- - - -
-
Net Income Available to Common
130.96M 66.33M (60.41M) (99.07M)
EPS (Basic)
1.5438 0.7948 -0.7349 -1.1889
EPS (Basic) Growth
+116.16% -48.52% -192.46% -61.78%
Basic Shares Outstanding
84.83M 83.47M 82.20M 83.33M
EPS (Diluted)
1.5259 0.7886 -0.7349 -1.1889
EPS (Diluted) Growth
+115.98% -48.32% -193.19% -61.78%
Diluted Shares Outstanding
85.83M 84.12M 82.20M 83.33M
EBITDA
249.88M 235.64M 194.02M 215.91M
EBITDA Growth
+24.71% -5.70% -17.66% +11.28%
EBITDA Margin
+13.07% +11.95% +9.73% +10.73%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 21.50
Number of Ratings 7 Current Quarters Estimate 0.32
FY Report Date 03 / 2026 Current Year's Estimate 2.186
Last Quarter’s Earnings 0.52 Median PE on CY Estimate N/A
Year Ago Earnings 2.084 Next Fiscal Year Estimate 2.301
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 6 6 7 5
Mean Estimate 0.32 0.54 2.19 2.30
High Estimates 0.41 0.62 2.39 2.48
Low Estimate 0.00 0.39 2.11 2.17
Coefficient of Variance 49.43 14.78 4.42 5.71

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 3 2
OVERWEIGHT 0 0 0
HOLD 5 4 5
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Pediatrix Medical Group Inc. - MD

Date Name Shares Transaction Value
Feb 27, 2025 Shirley A. Weis Director 18,360 Bona fide gift 0.00

Pediatrix Medical Group Inc. in the News